Amarin Corp Plc (AMRN)

[Williams4076]

Hey Raf,
Good point, but IMO FDA is again unclear with true message by using a double negative. Epanova was awarded 3 yrs NME at date of approval. Same time Vascepa was changed from 3 yrs NME so was Epanova..both had prior dates of expiration of NME...both changed to "There is no unexpired exclusivity for this product".

http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=205060&Product_No=001&table1=OB_Rx

The use the same term to mean different things...LOL just like Active Ingredient and Moiety....

BB